We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Device Simplifies Identification of Leishmania Hosts

By LabMedica International staff writers
Posted on 22 May 2017
Print article
Image: An illustration of one of two minimally invasive microbiopsy devices designed to simultaneously sample a person’s blood and skin in a way that mimics the mode of biting by which the sandflies acquire meals (Photo courtesy of the International Journal for Parasitology).
Image: An illustration of one of two minimally invasive microbiopsy devices designed to simultaneously sample a person’s blood and skin in a way that mimics the mode of biting by which the sandflies acquire meals (Photo courtesy of the International Journal for Parasitology).
Researchers have developed a novel device for obtaining essentially painless, minimally invasive microbiopsies (MBs) that mimic sand fly bites and meals, providing a convenient sampling method for identifying asymptomatic, potentially infectious carriers of Leishmania donovani in endemic areas.

Leishmania donovani species, parasites that cause visceral leishmaniasis (VL), are transmitted to humans by phlebotomine sandflies infected from a blood (+skin) meal taken upon biting an infected reservoir host animal – mainly humans (India and East Africa) or dogs (Latin America, Europe, Middle East, and North Africa). The majority of infected individuals remains asymptomatic, but serve as parasite reservoirs for transmission of the disease via sandflies. The gold standard for assessing infectiousness of human hosts to biting vector insects is xenodiagnosis – scoring infection rates among insectary-reared insects that had fed on humans suspected of being infected. However, when it comes to sandflies and leishmaniasis, xenodiagnosis is an intricate operation burdened by logistical hurdles and ethical concerns that prevent its effective application for population screening.

An international research team from Australia, Ethiopia, Israel, and USA, led by Alon Warburg, professor at Hebrew University Hadassah Medical School, has developed and tested minimally invasive microbiopsy (MB) devices designed to penetrate the skin to a depth of ∼200µm and absorb blood as well as skin cell lysates, mimicking the “pool-feeding” mode by which the sandflies acquire blood meals.

Using the devices, MBs taken from 137 of 262 volunteers in endemic VL foci in Ethiopia detected Leishmania parasites that could potentially be imbibed by sandflies upon feeding. Although the volume of MB samples was 10-fold smaller than finger-prick blood samples, Leishmania DNA detection rates from MBs were significantly higher, implying that skin, more often than blood, was the main source of parasites.

Volunteers with histories of VL were almost as likely as healthy volunteers to test positive by MBs, suggesting the importance of asymptomatic people as reservoir hosts. These MB devices could enable to reliably and efficiently assess both L. donovani infection rates among large numbers of asymptomatic carriers and their infectiousness to blood-feeding sandflies.

The study, by Kirstein OD et al, was published April 26, 2017, in the International Journal for Parasitology.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.